New York State Cancer Registry (NYSCR)

As part of the Meaningful Use (MU) Public Health Reporting Objective, the New York State Cancer Registry (NYSCR) is able to collect data from Eligible Professionals (EPs) both inside and outside the five boroughs of NYC.

As mandated by the Public Health Law, all NYS licensed health care providers and practitioners diagnosing or treating cancer patients, all licensed facilities at which patients are treated (e.g., hospitals, radiation centers), all laboratories holding permits to conduct pathology testing (whether independent or hospital-based), are required to report cancer cases to the NYSCR. Laws regarding cancer case reporting to the NYSCR apply to all providers in New York, including those in NYC.

As part of the MU Public Health Reporting Objective, reporting to the NYSCR is intended for EPs who diagnose and/or directly treat cancer. A diagnosing EP is one who definitively diagnoses cancer. The NYSCR considers an EP who directly treats cancer as one who performs/administers treatment modalities (i.e. surgery, radiation, chemotherapy, immunotherapy, hormonal therapy) directed at the cancer. Additionally, a treating EP could be one who decides (with the patient) that there will be no treatment given/received.

The information collected is quite extensive and includes, but is not limited to the primary site, histology (cell type), behavior (benign, in situ, malignant), stage, grade, diagnosis date, methods used to confirm the diagnosis, tumor markers, first course of treatment (including surgery, radiation, chemotherapy, immunotherapy, hormonal therapy, and active surveillance), and patient information (such as age, gender race, residence, and place of birth). Ideally, all of information about the patient required for cancer case reporting as part of MU will be collected or contained in the Electronic Health Record (EHR) for creation and transmission of a cancer case report.

The NYSCR contains reports of malignant cancers, included those with invasive and in situ behaviors. Intracranial tumors classified as benign or which have an uncertain behavior are also reportable, while some skin cancers and in situ cervical cancers are exempted. For MU cancer case reporting, the EHR software identifies reportable cancers for the provider, as specified by the implementation guide.

  • Meaningful Use Stage 1 (2011 – 2014): Not an Available Measure
  • Meaningful Use Stage 2 (2014): Cancer Case Reporting
  • Meaningful Use Modified Stage 2 (2015–2017): Specialized Registry Reporting
  • Meaningful Use Stage 3 (2017–2021): Public Health Registry Reporting

Phone: (518) 474–0971

Email: mdreports@health.ny.gov

Meaningful Use Stage 3 – 2015 Edition CEHRT

On July 15, 2016, the NYSCR declared they will be capable of accepting electronic cancer case reports from EPs located inside and outside the five boroughs of NYC, according to the standards required to meet the 2015 Edition CEHRT definition on or before January 1, 2017.

Meaningful Use Stage 2 & Modified Stage 2 – 2014 Edition CEHRT

As of 2014, the NYSCR began accepting electronic cancer case reports from EPs located inside and outside the five boroughs NYC, according to the standards required to meet the 2014 Edition CEHRT definition.

Meaningful Use Stage 1 – 2011 Edition CEHRT

The NYSCR was not accepting data for MU Stage 1.

EPs must register their intent to submit data for a given Public Health Reporting measure, before or within 60 days of the start of their EHR Reporting Period, using the Meaningful Use Registration for Public Health (MURPH) System. MURPH is the statewide system hosted on the Health Commerce System (HCS) that accepts registrations, is used by the registries, and used by the EHR Incentive Program to manage onboarding and program compliance. A registration must be completed for each EP. When an EP formally submit a registration, an e–mail confirmation will be sent to the Registration Contact´s e–mail from the MURPH System. Please see Public Health FAQ #4.1 regarding keeping the Registration Confirmations for post–payment audit purposes.

Please be aware that only one registration is needed if the EP is choosing to achieve multiple Public Health Reporting measures in the same Public Health jurisdiction. If the provider spans both jurisdictions, inside the 5 boroughs of NYC and outside the 5 boroughs of NYC, then a separate registration is needed for each jurisdiction.

Before an EP registers their intent to submit data to the NYSCR on the MURPH System, they should review the certification criteria to ensure the CEHRT being utilized is certified for Cancer Case Reporting. See the table below for the certification criteria:

CEHRT Edition MU Stage Implementation Guide Certification Criteria
2014 MU Stage 2; MU Modified Stage 2 Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries August 2012 §170.314(f)(5) Cancer Case Information; §170.314(f)(6) Transmission to Cancer Registries
2015 MU Stage 3 HL7 CDA ® Release 2 Implementation Guide: Reporting to Public Health Cancer Registries from Ambulatory Healthcare Providers, Release 1, DSTU Release 1.1 – US Realm §170.315(f)(4) Transmission to Cancer Registries

How to Access the MURPH Registration System:

  1. Log into HCS: https://commerce.health.state.ny.us*
  2. Click on the "My Content" on the top navigation bar
  3. Click on "All Application" in the drop down
  4. Click on the letter "M"
  5. Click on "Meaningful Use Registration for Public Health"

*An HCS account is required to submit a registration on the MURPH system. Account sign–up can be initiated from the HCS Login screen.

Note: Please see the Eligible Professional MURPH Registration Guide for additional details.

Step 1 Status

An EP who has submitted a registration through the MURPH System within 60 days of the start of their EHR Reporting Period has achieved Active Engagement Option 1 – Completed Registration to Submit Data and may attest ´Yes´ to the Public Health Reporting measure in an EHR Incentive Program attestation.

Once a registration is received, the Public Health Agencies (PHAs) will triage new registrants and prioritize EPs based on staff/resource availability, volume of data, practice size, reporting periods, and other criteria. If the registry chooses not to onboard the EP immediately following registration, the EP´s status will be recorded as Active Engagement Option 1 – Completed Registration to Submit Data. When the PHA staff is ready to work with the EP, an e–mail invitation will be sent to the registration and alternate contacts listed in the MURPH registration. At this time, the registry staff will change the EP´s status to ´´Invited to Test.´´ As soon as a timely response is received from the EP, PHA staff will change the status to Active Engagement Option 2 – Testing and Validation.

The measure may not be met if an EP fails to participate in the onboarding process as demonstrated by failure to respond to the PHA´s written request for action within 30 days on two separate occasions. Written requests to take action include invitations to begin testing, any requests for corrective action related to testing and validation, and any requests for corrective action while in production. Therefore, if an EP fails to respond to two requests for action before each 30–day time limit expires, the EP may be deemed "Non–Responsive" and not a meaningful user of CEHRT.

Note: The NYSCR will prioritize for testing based on criteria including, but not limited to, EP specialty. Specialties such as dermatology, urology, hematology, medical oncology, and gastroenterology, where cancer diagnosis and/or treatment frequently occur in the outpatient setting, are among those that will be given high priority.

Step 2 Status

An EP that has achieved Active Engagement Option 2 – Testing and Validation may attest ´Yes´ to the Public Health Reporting measure in an EHR Incentive Program attestation.

Now that a PHA has invited the EP to begin testing, the PHA will dedicate a representative to work closely with the EP to initiate the exchange and testing of data. The PHA will verify submitted test data for valid structure, content, and completeness. If any issues arise, the PHA may request EHR vendor/IT attention for troubleshooting, implementation of corrections, and continued testing.

The measure may not be met if an EP fails to participate in the onboarding process as demonstrated by failure to respond to the PHA´s written request for action within 30 days on two separate occasions. Written requests to take action include invitations to begin testing, any requests for corrective action related to testing and validation, and any requests for corrective action while in production. Therefore, if an EP fails to respond to two requests for action before each 30–day time limit expires, the EP may be deemed "Non–Responsive" and not a meaningful user of CEHRT. See Public Health FAQ #4.3 for additional information.

When an EP is invited to begin the testing process, the NYSCR will provide specific instructions related to the process.

Step 3 Status

An EP that has achieved Active Engagement Option 2 – Testing and Validation may attest "Yes" to the Public Health Reporting measure in an EHR Incentive Program attestation.

The NY Medicaid EHR Incentive Program defines submission of production data as an EP who continually and successfully submits structured, production–level data from a Certified EHR Technology to the appropriate PHA when the data is made available by the Certified EHR Technology and according to the timing and frequency determined by Public Health Law or registry policies. See Public Health FAQ #4.5 for additional information.

Submission of production data is initially achieved when the EP completes testing and validation and the PHA staff determines the EP´s live data is being received by the PHA and is correct in structure and content. When submission of production data is achieved, the EP´s status will be changed from Active Engagement Option 2 – Testing and Validation to Active Engagement, to Option 3 – Production. E–mail communications between the PHA and the EP indicating that submission of production data has been achieved is considered the EP´s acknowledgment of this status and should be saved for EHR Incentive Program audit purposes.

For additional information on audits please see Post–Payment Audit Guidance.

Step 4 Status

An EP that has achieved Active Engagement Option 3 – Production may attest ´Yes´ to the Public Health Reporting measure in an EHR Incentive Program attestation.